IRP
GSK icon

Investment Research Partners’s GSK GSK Stock Holding History

Investment Research Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$492K Buy
9,385
+1,196
+15% +$63.3K 0.17% 142
2026
Q1 		$452K Sell
8,189
-67
-0.8% -$3.63K 0.18% 130
2025
Q4 		$405K Sell
8,256
-46
-0.6% -$2.15K 0.17% 141
2025
Q3 		$381K Buy
+8,302
New +$324K 0.17% 140

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Investment Research Partners's GSK Position: Q2 2026 in Review

Investment Research Partners increased its GSK (GSK) stake by 15% in Q2 2026, buying an estimated $63.3K and bringing the position to 9,385 shares worth $492K. The position accounts for 0.17% of the portfolio, ranked #142.

Investment Research Partners first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Investment Research Partners held 9,385 shares of GSK worth $492K as of Q2 2026.
  • Investment Research Partners bought 1,196 GSK shares in Q2 2026, an estimated $63.3K.
  • GSK made up 0.17% of Investment Research Partners's portfolio in Q2 2026, its #142 holding.
  • Investment Research Partners first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • 798 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Investment Research Partners's 13F filing for Q2 2026, filed 4 Aug 2026.